Greater public awareness in the past decade, increased rural penetration of manufacturers , aggressive marketing by local companies and investments at an enhanced rate have accelerated the growth of pharma sector in Bangladesh.
Bangladesh market offers vast opportunities to leading Indian active pharma ingredient and intermediate manufacturers. The market is opening up in a big way and the concentration of global companies setting up presence
Pharmaceutical companies in Bangladesh which enjoys a number of competitive advantages hold huge potential for growth in the coming days. The industry's ability to comply with guidelines of quality assurance
Bal Pharma, medium-sized pharma enterprise in Karnataka has now been selected to market two of its formulations for government supplies in Bangladesh. The two products are Prednisalone, an anti inflammatory and Ethanbutal a TB drug.
Bangladesh pharmaceuticals and healthcare segment consisting of prescription drugs and over-the-counter medications, is set to grow by CAGR of 17.08 per cent to US$1.88 billion from US$858 million in the previous year.
Pharma is one of the most developed sectors contributing to the growth of Bangladesh economy. The key factors which has aided growth of this sector are the professional knowledge, thoughts and innovative